Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

Bioink manufacturers play an important role in bioprinting. Explore our list to see which companies are on the market.

A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...

Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical development of its lead experimental drug, AUTX-703, in blood cancers.

Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...

Prepare to get schooled If you have kids in school, or even if you don’t, you’ve probably realized that there’s a lot about ...

Mitolyn is a novel weight loss supplement that has been the subject of much discussion recently online. According to the manufacturers, the formula speeds up a slow metabolism and helps with sustained ...

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

In 2020-2021, a mysterious skin disease affected fishermen in Senegal. High levels of Portimine A toxin, produced by the ...

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...